Phillip Securities Group
Please note that the Day Light Saving of Europe and US will be effective on April 1st and March 11th respectively. The trading hours for those relevant contracts will be 1 hour earlier. Any questions, please contact us at 22776677.For details, please visit our foreign futures website or contact us at 22776677.Moreover,the spread of USD/JPY is low as one pip.Please click here for details
 
  Phillip Investor Notes

30-01-2024(Tue) 29-01-2024(Mon) 26-01-2024(Fri) 25-01-2024(Thu) 24-01-2024(Wed)
Page : 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 |
Investor Notes - Phillip Securities (HK) Ltd
Past Investor Notes  
Phillip Home Send to Friends Free Subscription Give Comments ¤¤¤åª©
24 Dec, 2020 (Thursday)

            
DONGFENG GROUP(489)
Analysis¡G
Dong Feng Motor Group (489) announced that onn 18 December 2020, the Company`s high-end new energy brand VOYAH launched the middle-and-large smart electric SUV VOYAH FREE in Shenzhen. It is currently fully open for appointment and will be delivered to users in the third quarter of 2021. From 2021 onwards, Voyah Automobile will place at least one new vehicle model in the market every year, and 40 direct sales outlets will be established nationwide by the end of 2021. In the next five years, the lineup of Voyah Automobile products will be constantly expanded in high-end electric vehicles by covering various segments such as sedans, SUV, MPV and other market segments. (I do not hold the above stock)
Strategy¡G
Buy-in Price: $8.10, Target Price: $9.00, Cut Loss Price: $7.60


WUXI BIO(2269)
Analysis¡G
Wuxi Biologics (2269) is principally engaged in the provision of end-to-end solutions and services for biologics discovery, development and manufacturing to customers involving in the biologics industry in both the PRC and other overseas countries. The company has recently announced that it will purchase from Bayer the Facility Assets of the biologics drug substance Manufacturing Plant located in Wuppertal, Germany. Together with the company¡¦s drug product facility in Leverkusen, Germany, acquired from the Previous Transaction, it allows the company to gain access to high quality biologics commercial manufacturing capacity and capabilities to meet clients¡¦ increasing demand for outsourced manufacturing services, as well as further enhance its global network to supply COVID-19 vaccines and other biologics.
Strategy¡G
Buy-in Price: $90.00, Target Price: $100.00, Cut Loss Price: $85.00



GWM (2333.HK) - November Sales Beat: Raise TP & Maintain Accumulate Rating

Investment Summary

Sales Volume in October Increases Rapidly, up 26% yoy

Great Wall Motors recently released sales data for October 2020. In November, the Company reported a sales volume of 145,200 vehicles, an increase of 26.12% yoy and an increase of 7.14% qoq. The cumulative sales volume in the first ten months reached 961,500 vehicles, a cumulative increase of 0.75% yoy, recording a positive growth rate yoy. Great Wall Motors continued the rapid sales growth in November, which was stronger than market expectations.

Haval and GWM Pickup Perform Outstandingly and the Company Remains Optimistic about the Market Outlook

In terms of sub-brands, Haval and GWM Pickup displayed outstanding performance.

1) Haval recorded a sales volume of 101,812 vehicles this month, an increase of 22.1% yoy. The increase mainly came from Haval H6, Haval Big Dog, Haval M6 and Haval H9. In particular, driven by the third-generation Haval H6, the sales volume of Haval H6 has outstripped 50,000 vehicles for two consecutive months, setting a new monthly high this year. After its launch in the market for three months, the sales volume of Haval Big Dog continued to climb, contributing 8,555 vehicles. Haval First Love, Haval Big Dog 2.0T, and the third-generation Haval H6 2.0T are to be launched. While continuing to improve the product map, the Company is expected to continue to improve its model structure and profit margin.

2) The WEY brand was sold by 9,122 vehicles, a decrease of 12.7% yoy. At the end of November and early December, the Company began to accept orders of the WEY Tank 300 officially. The order exceeded 10,000 vehicles in two weeks. The WEY Tank 300 is the first model of the Company's new modular vehicle platform "Tank". It is positioned as a smart luxury off-road SUV, with a price range of RMB176,000 to RMB214,000, which is slightly higher than the WEY VV7. After the launch of several new models, we look forward to a boost in sales volume of the WEY brand in 2021.

3) GWM Pickup reported a sales volume of 22,610 vehicles, up 18.6% yoy, exceeding 20,000 vehicles for two consecutive months. In particular, GWM Pao Pickup was sold by 12,100 vehicles, continuing to dominate the domestic high-end pickup market. With the addition of modified models such as its Rescue Pao and Brigade Pao, we continue to be optimistic that GWM Pickup will maintain strong sales performance.

4) The ORA brand was sold by 11,592 vehicles, a surge of 414.7% yoy, exceeding 10,000 vehicles for the first time. In particular, the sales volume of ORA Black Cat was 9,463 vehicles, an increase of 373% yoy and an increase of 51% qoq. The ORA Good Cat, which is positioned as the "new generation electric car", has been launched recently, with a price range of RMB103,900 to RMB143,900. It is expected to complement with the original model in a mismatched manner, and further enrich the product layout of the ORA brand.

Investment Thesis

Considering the better-than-expected Nov sales and revised financial forecast, we raised our target price to HK$19.7, equivalent to 29/17/12.8x P/E and 2.7/2.4/2.2x P/B ratio in 2020/2021/2022. We reaffirm the rating of ¡§Accumulate¡¨. (Closing price as at 17 December)

Risk

New vehicle sales fall short of expectations

The SUV market dramatically worsens

The progress of new energy vehicle/Pickup is poorer than expectations

Financials

Click Here for PDF format...




Recommendation on 24-12-2020
RecommendationAccumulate
Price on Recommendation Date$ 17.240
Suggested purchase priceN/A
Target Price$ 19.700
Writer Info
Zhang Jing
(Research Analyst)
Tel: (+86 21 51699400-103)
Email:
zhangjing@phillip.com.cn

Local Index
       Index    Change   Change%

World Index
       Index    Change   Change%
  

A-H spread
Stock Code H share
Price
A share
Price
H share
discount


Oversea Research Reports


Investment Service Centre



Enquiry : 2277 6666 OR investornotes@phillip.com.hk
If you cannot read this e-mail in the proper format, please click here to view the web version.

Information contained herein is based on sources that Phillip Securities (Hong Kong) Limited and/or its affiliates ( the ¡§Group¡¨) believe to be accurate. The Group does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The Group (or its employees) may have interests in relevant investment products. For details of different products¡¦ risks, please view the Risk Disclosures Statement on http://www.phillip.com.hk.

If you DO NOT wish to receive further marketing emails from us, please click HERE to opt-out.

ª©Åv©Ò¦³¡A ½¦L¥²¨s¡C

Copyright(C) 2020 Phillip Securities (HK) Ltd. All Rights Reserved.


Copyright © 2011 Phillip Securities Group. All Rights Reserved [ Risk Disclosures Statement ] [ Terms and Conditions ] [ Personal Data Policy ]